| Characteristic |
Aspergillosis |
Other mold |
Candida |
Negative control |
| |
(n=22) n (%) |
(n=17) n (%) |
(n=23) n (%) |
(n=20) n (%) |
| Age (years), median (range) |
60 (10-78) |
51 (22-73) |
55 (23-81) |
53 (18-71) |
| Gender |
| Male |
16 (73) |
9 (53) |
12 (52) |
10 (50.0) |
| Female |
6 (27) |
8 (47) |
11 (48) |
10 (50.0) |
| Underlying disease |
|
|
|
| Hematological |
22 (100) |
17 (100) |
11 (48) |
0 (0) |
| Solid tumor |
0 (0) |
0 (0) |
12 (52) |
20 (100) |
| HSCT |
12 (55) |
9 (53) |
2 (9) |
0 (0) |
| Antifungal therapy prior to PCR |
22 (100) |
17 (100) |
21 (91) |
2 (10) |
| Neutropenia at infection onset |
5 (23) |
6 (35) |
6 (26) |
1 (5) |
| Use of steroids |
17 (77) |
11 (65) |
9 (39) |
11 (55) |
| Immunotherapy |
18 (82) |
3 (76) |
10 (43) |
14 (70) |
|
